Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,396 shares at $295.84 ($3.7M) on 2023-02-14, disclosed to the SEC on 2023-02-16.
Seasonal sale ($3.7M) by EVP, COO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $295.84 | 800 | $237K | 6.4% |
| 2 | $295.84 | 800 | $237K | 6.4% |
| 3 | $296.85 | 901 | $267K | 7.2% |
| 4 | $296.85 | 901 | $267K | 7.2% |
| 5 | $298.14 | 560 | $167K | 4.5% |
| 6 | $298.14 | 560 |
| $167K |
| 4.5% |
| 7 | $299.13 | 2,003 | $599K | 16.2% |
| 8 | $299.13 | 2,003 | $599K | 16.2% |
| 9 | $300.09 | 1,734 | $520K | 14.1% |
| 10 | $300.09 | 1,734 | $520K | 14.1% |
| 11 | $300.89 | 400 | $120K | 3.3% |
| Total | $298.61 avg | 12,396 | $3.7M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |